Group 1 - Novavax, Inc. will participate in several upcoming investor conferences, including the TD Cowen 45th Annual Health Care Conference and the Leerink Partners 2025 Global Healthcare Conference [1][2] - The TD Cowen conference will feature a fireside chat on March 4, 2025, while the Leerink Partners conference will include a presentation on the same date [1] - A webcast of the events will be available on the company's website, with replays accessible for 30 days post-conference [2] Group 2 - Novavax focuses on addressing significant health challenges through its expertise in vaccines and advanced technology platforms, including a protein-based nanoparticle and Matrix-M™ adjuvant [3] - The company's growth strategy emphasizes forming new partnerships by out-licensing its technology and vaccine assets early in the development process [3] - Novavax aims to expand its early-stage pipeline, starting with infectious diseases and potentially branching into other areas [3]
Novavax to Participate in Upcoming March Investor Conferences